Vertiv Holdings Co vs 22nd Century Group Inc — how do they compare? Vertiv Holdings Co trades at $306.03 (market cap $112.03B), while 22nd Century Group Inc trades at $4.25 (market cap $1.49M). The key difference: Vertiv Holdings Co is far larger — about 75187.9× 22nd Century Group Inc's market cap, and Vertiv Holdings Co pays a 0.09% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| VRT | XXII | |
|---|---|---|
Market Cap | $112.03B | $1.49M |
Sector | Technology | Technology |
52-Week High | $376.23 | $1.07K |
52-Week Low | $121.82 | $3.90 |
Enterprise Value | $112.80B | -$6.74M |
Dividend Yield | 0.09% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XXII trades at $4.32, down 0.23% with bearish technical signals. The company shows negative profitability with -65.76% net income margin and -130.19% ROE, though valuation ratios appear low with P/S of 0.03. Recent corporate actions include a 20:1 reverse stock split in June 2026. The company is expanding VLN product distribution in key markets including California and New York, supported by positive FDA regulatory developments.
While analyst consensus is 75% buy-rated, fundamental challenges persist with consistent revenue declines and negative cash flow from operations. Investment opportunity lies in successful VLN brand expansion and regulatory approvals, but risks include ongoing losses, competitive tobacco market pressures, and execution uncertainty in scaling reduced-nicotine products.
Trailing returns across standard periods
Latest headlines on both assets
Vertiv is a global leader in critical digital infrastructure, providing essential power, cooling, and IT management solutions for data centers, communication networks, and industrial facilities. As the primary provider of advanced thermal management and liquid cooling systems, Vertiv is a central player in the AI revolution, enabling the extreme density and power requirements of next-generation GPU-driven computing.
Read more on VRT →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →